9-(benzothiazol-2-ylthio)-N-[2,4-bis(methylthio)-6-methyl-3-pyridyl]nonanamide | 835612-97-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: 9-(benzothiazol-2-ylthio)-N-[2,4-bis(methylthio)-6-methyl-3-pyridyl]nonanamide
• 英文别名: 9-(benzothiazol-2-ylthio)-N-[2,4-bis(methylthio)-6-methyl-pyridin-3-yl]nonanamide；9-(1,3-benzothiazol-2-ylsulfanyl)-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]nonanamide
• CAS: 835612-97-0
• 化学式: C₂₄H₃₁N₃OS₄
• 分子量: 505.794
• InChiKey: LRTBNZFYJWUYJZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.4
• 重原子数：
  32
• 可旋转键数：
  13
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  159
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• Novel amide compounds and medications containing the same
  申请人：Shibuya Kimiyuki

  公开号：US20050131002A1

  公开（公告）日：2005-06-16

  The present invention provides to a novel compound having an ACAT inhibiting activity. The present invention relates to compounds represented by formula (I) wherein represents an optionally substituted divalent residue such as benzene, pyridine, cyclohexane or naphthalene, or a group, Het represents a 5- to 8-membered, substituted or unsubstituted heterocyclic group containing at least one heteroatom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, such as a monocyclic group, a polycyclic group or a group of a fused ring, X represents —NH—, an oxygen atom or a sulfur atom, Y represents —NR 4 —, an oxygen atom, a sulfur atom, a sulfoxide or a sulfone, Z represents a single bond or —NR 5 —, R 4 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, R 5 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, and n is an integer of from 1 to 15, or salts or solvates thereof, and a pharmaceutical composition containing at least one of these compounds.

  本发明提供了一种具有ACAT抑制活性的新化合物。本发明涉及由式(I)表示的化合物，其中表示一种可选取代的二价残基，例如苯，吡啶，环己烷或萘，或者一个基团，Het表示一种5-至8-成员的取代或未取代的杂环基团，其中至少包含从氮原子，氧原子和硫原子中选取的一种杂原子，例如单环基团，多环基团或融合环的基团，X表示-NH-，氧原子或硫原子，Y表示-NR4-，氧原子，硫原子，亚砜或磺酰基，Z表示单键或-NR5-，R4表示氢原子，低碳基，芳基或可选取代的硅烷低碳基，R5表示氢原子，低碳基，芳基或可选取代的硅烷低碳基，n为1到15的整数，或其盐或溶剂，以及含有这些化合物中至少一种的药物组合物。
• Novel amide compounds and medications containing the same technical field
  申请人：Shibuya Kimiyuki

  公开号：US20050131001A1

  公开（公告）日：2005-06-16

  The present invention provides to a novel compound having an ACAT inhibiting activity. The present invention relates to compounds represented by formula (I) wherein represents an optionally substituted divalent residue such as benzene, pyridine, cyclohexane or naphthalene, or a group, Het represents a 5- to 8-membered, substituted or unsubstituted heterocyclic group containing at least one heteroatom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, such as a monocyclic group, a polycyclic group or a group of a fused ring, X represents —NH—, an oxygen atom or a sulfur atom, Y represents —NR 4 —, an oxygen atom, a sulfur atom, a sulfoxide or a sulfone, Z represents a single bond or —NR 5 —, R 4 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, R 5 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, and n is an integer of from 1 to 15, or salts or solvates thereof, and a pharmaceutical composition containing at least one of these compounds.

  本发明提供了一种具有ACAT抑制活性的新化合物。本发明涉及由式(I)表示的化合物，其中表示可选取代的二价残基，例如苯，吡啶，环己烷或萘，或基团，Het表示包含至少一种异原子（从氮原子，氧原子和硫原子中选择）的5-至8-成员取代或未取代的杂环基团，例如单环基团，多环基团或融合环基团，X表示-NH-，氧原子或硫原子，Y表示-NR4-，氧原子，硫原子，亚砜或磺酰基，Z表示单键或-NR5-，R4表示氢原子，低碳基，芳基或可选取代的硅基低碳基，R5表示氢原子，低碳基，芳基或可选取代的硅基低碳基，n为1至15的整数，或其盐或溶剂，以及含有这些化合物中至少一种的药物组合物。
• NOVEL AMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME
  申请人：KOWA COMPANY LTD.

  公开号：EP0979823A1

  公开（公告）日：2000-02-16

  The present invention provides to a novel compound having an ACAT inhibiting activity. The present invention relates to compounds represented by formula (I)    wherein represents an optionally substituted divalent residue such as benzene, pyridine, cyclohexane or naphthalene, or a group, Het represents a 5- to 8-membered, substituted or unsubstituted heterocyclic group containing at least one heteroatom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, such as a monocyclic group, a polycyclic group or a group of a fused ring, X represents -NH-, an oxygen atom or a sulfur atom, Y represents -NR4-, an oxygen atom, a sulfur atom, a sulfoxide or a sulfone, Z represents a single bond or -NR5-, R4 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, R5 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, and n is an integer of from 1 to 15, or salts or solvates thereof, and a pharmaceutical composition containing at least one of these compounds.

  本发明提供了一种具有 ACAT 抑制活性的新型化合物。 本发明涉及由式（I）代表的化合物 其中 代表任选取代的二价残基，如苯、吡啶、环己烷或萘，或代表一个基团、 Het 代表含有至少一个杂原子的 5 至 8 元、取代或未取代的杂环基团，该杂原子选 自氮原子、氧原子和硫原子组成的组，如单环基团、多环基团或融合环基团、 X 代表-NH-、氧原子或硫原子、 Y 代表-NR4-、氧原子、硫原子、亚砜或砜、 Z 代表单键或-NR5-、 R4 代表氢原子、低级烷基、芳基或任选取代的硅烷低级烷基、 R5 代表氢原子、低级烷基、芳基或任选取代的硅烷低级烷基，以及 n 是 1 至 15 的整数、 或其盐或溶剂，以及含有至少一种上述化合物的药物组合物。
• US6849647B1
  申请人：——

  公开号：US6849647B1

  公开（公告）日：2005-02-01
• US7393866B2
  申请人：——

  公开号：US7393866B2

  公开（公告）日：2008-07-01